BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12065747)

  • 1. Biomedicine. D-Day for BRCA2.
    Witt E; Ashworth A
    Science; 2002 Jul; 297(5581):534. PubMed ID: 12065747
    [No Abstract]   [Full Text] [Related]  

  • 2. The twists and turns in BRCA's path.
    Couzin J
    Science; 2003 Oct; 302(5645):591-3. PubMed ID: 14576418
    [No Abstract]   [Full Text] [Related]  

  • 3. A growing network of cancer-susceptibility genes.
    Venkitaraman AR
    N Engl J Med; 2003 May; 348(19):1917-9. PubMed ID: 12736286
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of Fanconi Anemia genes in familial breast cancer predisposition.
    Seal S; Barfoot R; Jayatilake H; Smith P; Renwick A; Bascombe L; McGuffog L; Evans DG; Eccles D; Easton DF; Stratton MR; Rahman N;
    Cancer Res; 2003 Dec; 63(24):8596-9. PubMed ID: 14695169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer. Complicated supercomplexes.
    Livingston DM
    Science; 2009 May; 324(5927):602-3. PubMed ID: 19407191
    [No Abstract]   [Full Text] [Related]  

  • 6. The Fanconi road to cancer.
    D'Andrea AD
    Genes Dev; 2003 Aug; 17(16):1933-6. PubMed ID: 12893780
    [No Abstract]   [Full Text] [Related]  

  • 7. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.
    Hussain S; Witt E; Huber PA; Medhurst AL; Ashworth A; Mathew CG
    Hum Mol Genet; 2003 Oct; 12(19):2503-10. PubMed ID: 12915460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interplay of Fanconi anemia proteins in the DNA damage response.
    Wang X; D'Andrea AD
    DNA Repair (Amst); 2004; 3(8-9):1063-9. PubMed ID: 15279794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PALB2 links BRCA1 and BRCA2 in the DNA-damage response.
    Zhang F; Ma J; Wu J; Ye L; Cai H; Xia B; Yu X
    Curr Biol; 2009 Mar; 19(6):524-9. PubMed ID: 19268590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of large genomic deletions in BRIP1, PALB2, and FANCD2 genes in BRCA1/2 negative familial breast cancer.
    Ameziane N; van den Ouweland AM; Adank MA; Vijzelaar RN; Errami A; Dorsman JC; Joenje H; Meijers-Heijboer H; Waisfisz Q
    Breast Cancer Res Treat; 2009 Dec; 118(3):651-3. PubMed ID: 19504183
    [No Abstract]   [Full Text] [Related]  

  • 11. Cancer. BRCA2 enters the fray.
    Wilson JH; Elledge SJ
    Science; 2002 Sep; 297(5588):1822-3. PubMed ID: 12228708
    [No Abstract]   [Full Text] [Related]  

  • 12. [Fanconi anemia and genomic instability].
    Kitao H; Fujinaka Y; Kubo N; Nakanoko T; Yoshinaga K; Tokunaga E; Saeki H; Endo K; Morita M; Kakeji Y; Maehara Y
    Fukuoka Igaku Zasshi; 2008 Jun; 99(6):115-22. PubMed ID: 18833937
    [No Abstract]   [Full Text] [Related]  

  • 13. New complexities for BRCA1 and BRCA2.
    Kerr P; Ashworth A
    Curr Biol; 2001 Aug; 11(16):R668-76. PubMed ID: 11525763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The DNA damage signalling kinase ATM is aberrantly reduced or lost in BRCA1/BRCA2-deficient and ER/PR/ERBB2-triple-negative breast cancer.
    Tommiska J; Bartkova J; Heinonen M; Hautala L; Kilpivaara O; Eerola H; Aittomäki K; Hofstetter B; Lukas J; von Smitten K; Blomqvist C; Ristimäki A; Heikkilä P; Bartek J; Nevanlinna H
    Oncogene; 2008 Apr; 27(17):2501-6. PubMed ID: 17982490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ten genes for inherited breast cancer.
    Walsh T; King MC
    Cancer Cell; 2007 Feb; 11(2):103-5. PubMed ID: 17292821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biallelic inactivation of BRCA2 in Fanconi anemia.
    Howlett NG; Taniguchi T; Olson S; Cox B; Waisfisz Q; De Die-Smulders C; Persky N; Grompe M; Joenje H; Pals G; Ikeda H; Fox EA; D'Andrea AD
    Science; 2002 Jul; 297(5581):606-9. PubMed ID: 12065746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fanconi anemia: Fanconi anemia, breast and embryonal cancer risk revisited.
    Howlett NG
    Eur J Hum Genet; 2007 Jul; 15(7):715-7. PubMed ID: 17505525
    [No Abstract]   [Full Text] [Related]  

  • 18. Heterozygosity for p53 (Trp53+/-) accelerates epithelial tumor formation in fanconi anemia complementation group D2 (Fancd2) knockout mice.
    Houghtaling S; Granville L; Akkari Y; Torimaru Y; Olson S; Finegold M; Grompe M
    Cancer Res; 2005 Jan; 65(1):85-91. PubMed ID: 15665282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FANCG promotes formation of a newly identified protein complex containing BRCA2, FANCD2 and XRCC3.
    Wilson JB; Yamamoto K; Marriott AS; Hussain S; Sung P; Hoatlin ME; Mathew CG; Takata M; Thompson LH; Kupfer GM; Jones NJ
    Oncogene; 2008 Jun; 27(26):3641-52. PubMed ID: 18212739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Connecting Fanconi anemia to BRCA1.
    Joenje H; Arwert F
    Nat Med; 2001 Apr; 7(4):406-7. PubMed ID: 11283658
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.